Page last updated: 2024-09-03

afdx 384 and Body Weight

afdx 384 has been researched along with Body Weight in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellucci, A; Casamenti, F; Costagli, C; Pepeu, G; Scali, C; Schmidt, B1
Buccafusco, JJ; Zhang, LC1
Berlan, M; Galitzky, J; Merial, C; Montastruc, JL; Pelat, M; Senard, JM; Verwaerde, P1

Other Studies

3 other study(ies) available for afdx 384 and Body Weight

ArticleYear
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:7-8

    Topics: Acetylcholine; Aging; Animals; Body Weight; Brain; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Administration Schedule; Hippocampus; Indans; Male; Muscarinic Antagonists; Phenylcarbamates; Piperidines; Pirenzepine; Rats; Rats, Inbred F344; Rivastigmine; Trichlorfon

2002
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
    Brain research, 1998, Aug-24, Volume: 803, Issue:1-2

    Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intravenous; Injections, Subcutaneous; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Substance Withdrawal Syndrome; Vasomotor System

1998
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:5

    Topics: Adenylyl Cyclases; Animals; Blood Pressure; Body Weight; Dogs; Dose-Response Relationship, Drug; Heart Atria; Hypertension; Male; N-Methylscopolamine; Obesity; Pirenzepine; Receptor, Muscarinic M2; Receptors, Muscarinic

1999